Hauptmann N, Pion M, Wehner R, Munoz-Fernandez MA, Schmitz M, Voit B, Appelhans D (2014)
Publication Type: Journal article
Publication year: 2014
Book Volume: 15
Pages Range: 957-967
Journal Issue: 3
DOI: 10.1021/bm401845b
Dendritic cells (DCs) play a crucial role in the development of cell-mediated immunotherapy due to their ability to induce and maintain strong immune responses. In our study, we evaluated a biocompatible Ni(II)-NTA-modified poly(ethylene imine) dendritic glycopolymer (Ni(II)-NTA-DG) as new carrier system to increase the antigen uptake into iDCs for future DC-based immunotherapy. Ni(II)-NTA-DG led to an increase in His
APA:
Hauptmann, N., Pion, M., Wehner, R., Munoz-Fernandez, M.-A., Schmitz, M., Voit, B., & Appelhans, D. (2014). Potential of Ni(II)-NTA-modified poly(ethylene imine) glycopolymers as carrier system for future dendritic cell-based immunotherapy. Biomacromolecules, 15(3), 957-967. https://dx.doi.org/10.1021/bm401845b
MLA:
Hauptmann, N., et al. "Potential of Ni(II)-NTA-modified poly(ethylene imine) glycopolymers as carrier system for future dendritic cell-based immunotherapy." Biomacromolecules 15.3 (2014): 957-967.
BibTeX: Download